Validation of BTK & Aiolos Immunophenotyping Assay to Monitor B, NK & T cell Responses as a Clinical Biomarker in B-cell Malignancies
Découvrez nos ressources
Types de ressources
Thèmes
-
Download Poster Validation of BTK & Aiolos Immunophenotyping Assay to Monitor B, NK & T cell Responses as a Clinical Biomarker in B-cell Malignancies
-
Download Poster Validation of a Whole Blood and Proteomic Stabilized Blood Assay to Monitor the Engagement and Modulation of CD6 on T cells by Itolizumab as a Clinical Pharmacodynamic
Validation of a Whole Blood and Proteomic Stabilized Blood Assay to Monitor the Engagement and Modulation of CD6 on T cells by Itolizumab as a Clinical Pharmacodynamic
-
Download Poster Evaluation of total PD-1 expression using multi-color flow cytometry in Metastatic Non-Small Cell Lung Cancer patients treated with Multi-Neoantigen Vector (ADXS-503) in
Evaluation of total PD-1 expression using multi-color flow cytometry in Metastatic Non-Small Cell Lung Cancer patients treated with Multi-Neoantigen Vector (ADXS-503) in
%20in.jpg?width=270&height=350&name=93.%20Evaluation%20of%20total%20PD-1%20expression%20using%20multi-color%20flow%20cytometry%20in%20Metastatic%20Non-Small%20Cell%20Lung%20Cancer%20patients%20treated%20with%20Multi-Neoantigen%20Vector%20(ADXS-503)%20in.jpg)
-
Download Poster Development and technical validation of tetramer staining for use as a biomarker for assessing gluten-specific T cells in clinical studies
Development and technical validation of tetramer staining for use as a biomarker for assessing gluten-specific T cells in clinical studies
-
Download Poster Etrasimod’s Role on Immune Cells in Ulcerative Colitis
Etrasimod’s Role on Immune Cells in Ulcerative Colitis
-
Download Poster Epigenetic assays for leukocyte subpopulations identification in sepsis cohort
Epigenetic assays for leukocyte subpopulations identification in sepsis cohort
-
Download Poster Etrolizumab Treatment Increases Blood Levels of CD3, Treg and Th17 Cells Measured Through Epigenetic Activation of CD3, FOXP3 and IL-17 Loci
Etrolizumab Treatment Increases Blood Levels of CD3, Treg and Th17 Cells Measured Through Epigenetic Activation of CD3, FOXP3 and IL-17 Loci
-
Download Poster Interim biomarker analysis of etigilimab in advanced solid tumors
Interim biomarker analysis of etigilimab in advanced solid tumors
